Covid Pneumonia in a Female with Metabolic Syndrome – A Case Report
Abstract
Evidence across the globe indicates that among patients with confirmed SARS-CoV-2 infection, the outcomes were severe in those with diabetes, obesity, and hypertension with a high incidence of mortality regardless of age. We came across a 43-year-old obese female with type 2 diabetes and hypertension diagnosed with SARS-CoV2 infection. She presented with fever and cough for the previous 3-5 days and subsequently developed breathlessness. Laboratory investigations and radiological findings confirmed the diagnosis of SARS-CoV-2 infection. Our patient had dyspnea and higher CRP, NLR, and LDH than these threshold values with a CTSS of 17 and SpO2 <71%. Moreover, the patient was previously diagnosed with metabolic syndrome. Considering the clinical status, she was hospitalized and managed as per COVID-19 protocol. Even thoughat high-risk, the patient recovered well due to the efficient team-work and the holistic approach at our hospital.
References
2. Batista DV, Vieira CAFA, Costa TA, Lima EG. COVID-19- associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes on SGLT2 inhibitor: a case report. Diabetol Int. 2020;12(3):313-316. Published 2020 Oct 28. doi:10.1007/ s13340-020-00473-3
3. Clark CE, McDonagh STJ, McManus RJ. et al. COVID-19, and hypertension: risks and management. A scientific statement on behalf of the British and Irish Hypertension Society. J Hum Hypertens.2021;35:304–307. https://doi.org/10.1038/ s41371-020-00451-x